Intellectus Partners’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $711K | Sell |
176,550
-28,500
| -14% | -$115K | 0.15% | 165 |
|
2025
Q1 | $560K | Sell |
205,050
-1,000
| -0.5% | -$2.73K | 0.14% | 181 |
|
2024
Q4 | $876K | Buy |
206,050
+16,350
| +9% | +$69.5K | 0.19% | 142 |
|
2024
Q3 | $558K | Sell |
189,700
-7,850
| -4% | -$23.1K | 0.14% | 178 |
|
2024
Q2 | $687K | Sell |
197,550
-18,300
| -8% | -$63.7K | 0.19% | 148 |
|
2024
Q1 | $615K | Buy |
215,850
+1,500
| +0.7% | +$4.28K | 0.16% | 166 |
|
2023
Q4 | $757K | Sell |
214,350
-23,025
| -10% | -$81.3K | 0.22% | 127 |
|
2023
Q3 | $615K | Buy |
237,375
+3,250
| +1% | +$8.42K | 0.19% | 147 |
|
2023
Q2 | $922K | Buy |
234,125
+14,750
| +7% | +$58.1K | 0.28% | 103 |
|
2023
Q1 | $741K | Buy |
219,375
+36,600
| +20% | +$124K | 0.23% | 123 |
|
2022
Q4 | $654K | Buy |
182,775
+17,210
| +10% | +$61.6K | 0.23% | 132 |
|
2022
Q3 | $667K | Buy |
165,565
+3,350
| +2% | +$13.5K | 0.24% | 119 |
|
2022
Q2 | $723K | Buy |
+162,215
| New | +$723K | 0.25% | 112 |
|
2022
Q1 | – | Sell |
-174,125
| Closed | -$1.54M | – | 237 |
|
2021
Q4 | $1.54M | Sell |
174,125
-18,250
| -9% | -$161K | 0.39% | 63 |
|
2021
Q3 | $2M | Buy |
192,375
+22,800
| +13% | +$237K | 0.48% | 51 |
|
2021
Q2 | $1.78M | Buy |
+169,575
| New | +$1.78M | 0.4% | 61 |
|
2021
Q1 | – | Sell |
-92,500
| Closed | -$1.03M | – | 244 |
|
2020
Q4 | $1.03M | Buy |
+92,500
| New | +$1.03M | 0.31% | 100 |
|